Ellen de Kort

38 Chapter 2 34. Giannantonio C, Sammartino M, Valente E, Cota F, Fioretti M, Papacci P. Remifentanil analgosedation in preterm newborns during mechanical ventilation. Acta Paediatr 2009;98:1111- 1115. 35. Pereira e Silva Y, Gomez RS, de Oliveira Marcatto J, Maximo TA, Ferreira Barbosa R, Simoes e Silva C. Early awakening and extubation with remifentanil in ventilated premature neonates. Paediatr Anaesth 2008;18:176-183. 36. Pereira e Silva Y, Gomez RS, de Oliveira Marcatto, Maximo TA, Ferreira Barbosa R, Simoes e Silva C. Morphine versus remifentanil for intubating preterm neonates. Arch Dis Child Fetal Neonatal Ed 2007;92:F293-F294. 37. Sammartino M, Bocci MG, Ferro G, Mercurio G, Papacci P, Conti G, et al. Efficacy and safety of continuous intravenous infusion of remifentanil in preterm infants undergoing laser therapy in retinopathy of prematurity: clinical experience. Paediatr Anaesth 2003;13:596-602. 38. Sammartino M, Garra R, Sbaraglia F, De Riso M, Continolo N, Papacci P. Experience of remifentanil in extremely low-birth-weight babies undergoing laparotomy. Pediatr Neonatol 2011;52:176-179. 39. Pereira e Silva Y, Gomez RS, Ferreira Barbosa R, Simoes e Silva AC. Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome. Paediatr Anaesth 2005;15:993-996. 40. Vanderhaegen J, Naelaers G, S. van Huffel, C. Vanhole, Allegaert K. Cerebral and systemic hemodynamic effects of intravenous bolus administration of propofol in neonates. Neonatology 2010;98:57-63. 41. Allegaert K, Peeters MY, Verbesselt R, Tibboel D, Naulaers G, de Hoon JN, et al. Inter- individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007;99:864-870. 42. Thewissen L, Allegaert K. Analgosedation in neonates: do we still need additional tools after 30 years of clinical research? Arch Dis Child Fetal Neonatal Ed 2011;96:112-118. 43. Allegaert K, Peeters MY, Knibbe C. Propofol in (pre)term neonates: consider the extensive interindividual variability in clearancewithin the neonatal population. Paediatr Anesth 2011;21:174- 175. 44. Simons SHP, van der Lee R, Reiss IKM, van Weissenbruch MM. Clinical evaluation of propofol as sedative for endotracheal intubation in neonates. Acta Paediatr 2013;102:e487-e492. 45. Papoff P, Mancuso M, Caresta E, Moretti C. Effectiveness and safety of propofol in newborn infants. Pediatrics 2208;121:448-449. 46. Veyckemans F. Propofol for intubation of the newborn? Paediatr Anaesth 2001;11:630-631. 47. Nauta M, Onland W, De Jaegere A. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm infants. Paediatr Anaesth 2011;21:711-712. 48. Lemyre B, Doucette J, Kalyn A, Gray S, Marrin ML. Morphine for elective endotracheal intubation in neonates: a randomized trial. BMC Pediatrics 2004;4:20. 49. Norman E, Wilkström S, Hellström-Westas L, Turpeinen U, Hämäläinen E, Fellman V. Rapid sequence inducation is superior to morphine for intubation of preterm infants: a randomized controlled trial. J Pediatr 2011;159:893-899. 50. Deshpande G, Gill A. Cardiac arrest following naloxone in an extremely preterm neonate. Eur J Pediatr 2009;168:115-117.